Population Effectiveness of Dolutegravir Implementation in Uganda: A Prospective Observational Cohort Study (DISCO), 48-Week Results

Abstract Background Tenofovir/lamivudine/dolutegravir (TLD) is the preferred first-line antiretroviral therapy (ART) regimen for people with HIV (PWH), including those who were previously virologically suppressed on nonnucleoside reverse transcriptase inhibitors (NNRTIs). We sought to estimate the r...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of infectious diseases 2024-09, Vol.230 (3), p.e622-e630
Hauptverfasser:	McCluskey, Suzanne M, Muyindike, Winnie R, Nanfuka, Victoria, Omoding, Daniel, Komukama, Nimusiima, Barigye, Ian T, Kansiime, Lydia, Tumusiime, Justus, Aung, Taing N, Stuckwisch, Ashley, Hedt-Gauthier, Bethany, Marconi, Vincent C, Moosa, Mahomed-Yunus S, Pillay, Deenan, Giandhari, Jennifer, Lessells, Richard, Gupta, Ravindra K, Siedner, Mark J
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiretroviral drugs Antiretroviral therapy Clinical trials Cohort analysis Drug resistance Editor's Choice Lamivudine Major Non-nucleoside reverse transcriptase inhibitors Population studies RNA-directed DNA polymerase Tenofovir
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!